Vivanza Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	70	70	80	272	752	755
Market Cap Growth	-18.60%	-11.56%	-70.69%	-63.88%	-0.34%	44.45%
Enterprise Value	171	166	140	322	807	784
Last Close Price	1.75	1.76	1.99	6.79	18.80	18.86
PE Ratio	17.50	17.85	-	49.63	125.69	226.61
PS Ratio	0.06	0.06	1.07	0.97	4.14	6.74
PB Ratio	1.61	1.62	2.01	5.86	18.38	21.61
P/TBV Ratio	2.57	2.59	3.42	9.05	30.62	40.63
P/FCF Ratio	-	-	-	13.54	-	30.59
P/OCF Ratio	-	-	-	13.29	-	30.59
EV/Sales Ratio	0.15	0.14	1.88	1.16	4.44	7.00
EV/EBITDA Ratio	20.28	19.62	-	28.78	70.90	91.48
EV/EBIT Ratio	20.81	20.14	-	29.10	71.06	92.28
EV/FCF Ratio	-6.34	-	-	16.07	-	31.78
Debt / Equity Ratio	2.34	2.34	2.18	1.12	1.96	1.58
Debt / EBITDA Ratio	12.07	12.07	-	4.61	7.03	6.43
Debt / FCF Ratio	-	-	-	2.58	-	2.23
Net Debt / Equity Ratio	2.32	2.32	2.15	1.07	1.91	1.56
Net Debt / EBITDA Ratio	11.99	11.99	-29.22	4.44	6.88	6.36
Net Debt / FCF Ratio	-3.75	-3.75	-3.39	2.48	-8.28	2.21
Asset Turnover	6.02	6.02	0.42	1.33	0.96	0.93
Inventory Turnover	39.36	39.36	3.20	11.58	6.73	6.26
Quick Ratio	0.74	0.74	0.90	0.96	0.75	0.83
Current Ratio	1.13	1.13	1.35	1.29	1.15	1.31
Return on Equity (ROE)	9.48%	9.48%	-15.67%	12.54%	15.78%	10.01%
Return on Assets (ROA)	2.67%	2.67%	-1.06%	3.30%	3.73%	4.42%
Return on Invested Capital (ROIC)	4.17%	4.43%	-2.76%	8.11%	9.09%	10.91%
Return on Capital Employed (ROCE)	15.70%	15.70%	-4.20%	15.10%	20.50%	14.00%
Earnings Yield	5.63%	5.60%	-8.47%	2.02%	0.80%	0.44%
FCF Yield	-38.62%	-38.40%	-31.49%	7.39%	-1.26%	3.27%
Buyback Yield / Dilution	1.40%	1.40%	-2.32%	2.27%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.